This study evaluates a new rehabilitation approach for stroke survivors in the chronic phase
of recovery in which the combination of drug therapy (cyproheptadine) and active movement
practice (AMP) is used to encourage increased voluntary muscle control and strength.
Phase:
N/A
Details
Lead Sponsor:
Rehabilitation Institute of Chicago Shirley Ryan AbilityLab
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institutes of Health (NIH)